Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T14:17:12.241Z.
Calculation as of: 2026-10-06T14:17:12.241Z.
Quote observation: 2026-10-06T14:15:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9f9faf5d94760910c623181769e7db2d3dbfaf2deb8efb054b569f6f0254c4bb
PE RATIO
N/A
Jaguar Health, Inc.
Market Cap
$2.99M
PE Ratio
N/A
| NAME | MARKET CAP | PE RATIO |
|---|---|---|
| Jaguar Health, Inc. (JAGX) | $2.99M | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.64M | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.59M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.05M | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.53M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.17M | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.50M | N/A |
| iTonic Holdings Ltd. (ITOC)vs › | $2.38M | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.35M | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$6.88
Forward EPS (Est.)
$-63.00
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
